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Iran is a tropical country with a land area of
1,648,000 square kilometers and a population of
68,100,000. Iran has a recorded history that dates
back 2553 years. Its earliest medical school was
Pasargad. Jondi Chapour University was founded
1753 years ago during the Sassanid dynasty as a
center for higher education in medicine, philosophy,
and pharmacology. Indeed, the idea of xenotrans-
plantation dates back to days of Achaemenidae
(Achaemenian dynasty), as evidenced by engrav-
ings of many mythologic chimeras still present in
Persepolis. Avicenna (980-1037 AD), the great
Iranian physician, performed the first nerve repair.
Transplantation progress in Iran follows roughly
the same pattern as that of the rest of the world,
with some 10-20 years’ delay. Modern organ trans-
plantation dates back to 1935, when the first cornea
transplant was performed at Farabi Hospital in
Tehran, Iran. The first living-related kidney trans-
plantation performed at Shiraz University Hospital
dates back to 1968. The first bone marrow trans-
plant was performed at Dr. Shariaati’s Hospital in
Tehran. The first heart transplant was performed
1993 in Tabriz, Iran. The first liver transplant was
performed in 1993 in Shiraz. The first lung trans-
plant was performed in 2001, and the first heart
and lung transplants were performed in 2002,
both at Tehran. In late 1985, the renal transplanta-
tion program was officially started in a major
university hospital in Tehran and was poised to
carry out 2 to 4 transplantations each week. Soon,
another large center initiated a similar program.
Both of these centers accepted surgical, medical,
and nursing teams from other academic medical
centers for training in kidney transplantation. Since
2002, Iran has grown to include 23 active renal, 68
cornea, 2 liver, 4 heart, 2 lung, and 2 bone marrow
transplantation centers in different cities. 
In June 2000, the Organ Transplantation Brain
Death Act was approved by the Parliament,
followed by the establishment of the Iranian
Network for Transplantation Organ Procurement.
This act helped to expand heart, lung, and liver
transplantation programs. By 2003, Iran had
performed 131 liver, 77 heart, 7 lung, 211 bone
marrow, 20,581 cornea, and 16,859 liver tranplan-
tations. Sources of these donations were living-
unrelated donor, 82%; cadaver, 10%; and living-
related donor, 8%. The 3-year renal transplant
patient survival rate was 92.9%, and the 40-month
graft survival rate was 85.9%. 
Another large step in expanding the transplan-
tation program is the construction of the Avi-
Cenna (Abou Ali Sina) Transplant Hospital in
Shiraz. This hospital hopefully will begin operation
in 2 years. It will offer the opportunity for the
exchange and sharing of organs and increased
cooperation between transplant teams in the
Middle East. The hospital offers great promise for
transplant medicine in Iran and other Persian Gulf
countries.
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Chapour University was founded 1753 years ago
during the Sassanid dynasty as a center of higher
education for medicine, philosophy, and pharma-
cology [1]. Jondi Chapour University was one the
biggest centers for the sciences at that time.
Transplantation has a long history in Iran. Indeed,
the idea of xenotransplantation dates back to the
glorious days of Achaemenidae, as evidenced by
engravings of many mythologic chimeras still
present in Persepolis, manifesting the idea of
chimerism with the body of lion and the head of
human. Creatures of this kind appear in different
parts of Iran like the very impressive chimera in
Gheissarieh Bazar of Isfahan. Avicenna (980-1037
AD), the great Iranian physician, performed the first
nerve repair [2]. Transplantation progress in Iran
follows roughly the same pattern as that of the rest
of the world, with some 10-20 years’ delay. The first
cornea transplant was followed by first kidney
transplantation 37 years ago in Shiraz [3]. The first
bone marrow transplant was performed at Dr.
Shariaati’s University Hospital in Tehran in 1990 [4].
The first heart transplant was performed 1993 in
Tabriz, Iran [2]. The first liver transplant was
reported in Shiraz Namazi University Hospital in
1993 by Dr. Malek-Hosseini [5]. The first lung trans-
plant was performed in 2001 followed by a heart
and lung transplant in 2002 [2]. 
The eye bank in Iran is a nonprofit nongovern-
mental organization established in 1988 that by 2003
had performed more than 20,000 corneal trans-
plants. This organization can provide a cornea for
transplantation in 48 hours in emergency cases, the
usual waiting time for a corneal or scleral transplant
is 2 weeks [6].
Following the first living-related kidney trans-
plant performed at Shiraz University Hospital in
1968, 112 renal transplantations had been
performed from living-related donors by 1980. Two
cadaver kidneys were transplanted in Shiraz and
Tehran, and 14 cadaver kidneys imported through
the Eurotransplantation Network were transplant-
ed from 1968 to 1980 [3]. It should be mentioned
that in 1975, the number of end-stage renal disease
(ESRD) patients undergoing maintenance
hemodialysis was fewer than 60 nationwide, so one
could not expect a much higher number of trans-
plants to be performed during this period. An office
of ESRD management was established by Iran’s
Ministry of Health, which helped to expand dialysis
facilities. Consequently, the number of patients
undergoing chronic maintenance hemodialysis
increased rapidly after 1975. There was a period of
slow transplantation activities from 1980 to 1984.
Subsequently, in late 1985, the renal transplantation
program was officially started in a major university
hospital in Tehran by Professor Iraj Fazel and was
set to carry out 2 to 4 transplantations per week.
Soon after, another large center initiated a similar
program. Both of these centers accepted surgical,
medical, and nursing teams from other academic
medical centers for training in kidney transplanta-
tion [7]. Between 1985 and 1987, 274 renal trans-
plants were performed from living-related donors
(LRDs) in these 2 centers [7]. As maintenance
hemodialysis was expanding rapidly and the
number of LRDs could not meet the needs of the
transplantation candidates, a controlled living-
unrelated donor (LURD) program was begun in
1988 [7]. This program coincided with an increase in
the number of transplantation units and resulted in
rapid growth of the number of renal transplants
performed. The number of LRDs decreased while
the number of LURDs increased. Since 2001, there
are 23 active renal transplantation centers (0.367 per
million population) in different cities of Iran (Figure
1) [8]. All of these centers are in university hospitals. 
In the last 5 years, 3 private hospitals have begun
kidney transplant programs on a small scale.
Between 1985 and 2003, a total of 16,859 renal trans-
plants had been reported by the management center
for transplantation [9]. The sources of donors were
LURD, 82%; cadaver, 10%; and LRD, 8%. In one
report, it was found that 85% of LURD renal trans-
plant recipients had a potential LRD. The 3-year
patient survival rate was reported to be 92.9%, and
the 40-month graft survival was 85.9% (Figure 2).
Namely that there was no significant difference
regarding patient and graft survival between LRD
and LURD transplants [10]. 
Nonnative Iranians are not permitted to receive
organs for transplantation from Iranian LURDs. If a
nonnative Iranian needs an organ transplantation
while in Iran, they must bring the donor from their
own country.
During the pretransplantation workup for the
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Figure 1. The Number of Transplantation Centers in Iran from 1984 to 2001
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LURD, the nephrologist emphasizes the advantages
of LRD compared with LURD with respect to
kidney transplantation outcomes. These advantages
are less early onset of acute rejection, better graft
survival rates, and the need for less immunosup-
pressive medications in cases of negative HLA
cross-matching. If recepients have no living related
donors, they are referred to the Dialysis and
Transplant Patients Association (DATPA) to find a
suitable unrelated donor. All the members of
DATPA are themselves patients who are maintained
on some sort of renal replacement therapy, either
maintenance hemodialysis, or continous ambulato-
ry peritoneal dialysis, or they have undergone renal
transplantation. After the workup, if the donor is
suitable, they will be referred to one of the trans-
plant units. Following transplantation, donors
receive a gift from the government as a reward. The
majority of the unrelated donors recieve supple-
mental compensation, equivalent to US $1550 from
the recipients. 
Although admittedly, the program of LURD trans-
plants is one of the barriers to expanding cadaveric
renal transplantion, it also has lowered the number of
LRDs. This practice is defended by the statement, “I
admit that the best practice of renal transplantation
can only be accomplished by an effective cadaveric
renal transplant program; but in its absence and
when adequate numbers of LRD transplants are not
avaiable, the adoption of a controlled LURD renal
transplant program remains the only alternative.
Otherwise, many patients will have to stay on
dialysis forever, without being given the chance to
receive a renal transplant. Finally, in the presence of
a controlled LURD renal transplant program, which
is closely monitored by national societies and trans-
plant teams, the development of uncontrolled,
commercial, and illegal LURD renal transplantation
is prevented” [10].
In several series, most renal transplant recipients
have been between the ages of 20 and 40 years
[8,11]. Although there has not been a waiting list for
kidney transplatation since 1999, one should
consider the fact that many dialysis patients still are
not scheduled for renal transplantation and
continue chronic hemodialysis [12]. According to
the Center for Management of Organ Transplan-
tation, the distributions of patients on renal replace-
ment therapy are as follows: hemodialysis, 51%;
continous ambulatory peritoneal dialysis, 1%; and
transplant, 48% (Figure 3) [6]. The explanation for
less acceptance of renal transplantation as the
treatment of choice for patients with ESRD is that
both they and their physicians do not consider renal
transplantation a preferred choice, preferring to
continue on dialysis instead [12]. This indicates the
need for greater public education. Another major
barrier to renal transplantation in Iran is the
country’s geographic constraints. Many patients
who are candidates for renal transplantation are
from remote rural areas, and long-term posttrans-
plant follow-up would be hard for them. one of the
studies reveals that 2864 of 8409 patients (34.1%)
patients were lost to follow-up [13].
In June 2000, the Organ Transplantation and
Brain Death Act was approved by the Parliament
[14]. According to the law, brain death must be
diagnosed and certified by 4 physicians, including a
neurologist, a neurosurgeon, an internist, and an
anesthesiologist, none of whom can be part of a
transplantation team. After brain death is confir-
med, cadaveric organ tissues are used for transplan-
tation if the deceased had signed a donor card or
consent had been given by the next of kin. Passage
of this law was followed by establishment of the
Iranian Network for Transplantation Organ Procure-
ment (IRANTOP). This network was created to
expand heart, lung, and liver transplantations. In
2003, there were 1640 kidney, 49 liver, 20 heart, 2 lung,
211 bone marrow, and 2581 cornea transplantations.
Currently, there are 23 kidney, 2 liver, 4 heart, 2 lung,
2 bone marrow, and 68 cornea transplant units in
different cities in Iran.
Since 1985, there have been 16,859 renal, 131 liver,
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Figure 3. HD, Hemodialysis; CAPD, Chronic ambuatory peritoneal
dialysis 
Renal Replacement Therapy in Iran
Figure 2. Patient and Graft Survival 
77 heart, 7 lung, and 2 heart and lung transplant
operations in Iran. IRANTOP organized 17 centers to
find patients with brain death and 7 centers to obtain
tissues and organs for transplantation. A summary of
the activities of IRANTOP is shown in Figure 4. The
activities of IRANTOP resulted in the donation of 47
cadavers, which were used in 23 liver transplants
during the first 6 months of 2003. During the first 6
months of 2004, 28 liver transplants were performed
from 51 cadavers, while simultaneously, 764 renal
transplants were performed, 12.90% from cadavers
and 87.10% from living donors [6]. Figure 5 shows
the growth of IRANTOP activities since the Brain
Death Act was approved in 2000 and its effect on
different organ transplantations.
The first liver transplantation in Iran was
performed on May 4, 1993, in Shiraz [15]. However,
the shortage of available cadaver livers owing to
various social and legal issues remains a crippling
problem. In an attempt to overcome the problem,
living-related liver transplantation was started in
Shiraz [16]. Another promising step to expand the
transplantation program in Iran is the construction
of the Avicena (Abou Ali Sina) Transplant Hospital
in Shiraz. This hospital hopefully will begin
operation in 2 years. It will provide the opportunity
for the exchange and sharing of organs and
increased cooperation between transplant teams in
the Middle East. The hospital offers great promise
for transplant medicine, in Iran and in many other
Persian Gulf countries.
Finally, we must recognize that organ transplan-
tation encompasses not only medical, legal, and
ethical aspects, but economic issues as well. In one
study, 500 LURDs and their recipients were
grouped according to socioeconomic status. The
results showed that 84.0% of LURDs were poor and
16% were middle class. Of the 500 recipients, 50.4%
were poor, 36.2% were middle class, and 13.4%
were wealthy [17]. Presently, there is no fee for
transplantation incurred by patients; all hospital
charges are paid for by the government. The cost of
renal transplantion is approximately US $10,000-
$15,000, and the cost of liver transplantation is
approximately US $22,000. This is much less
expensive than that for neighboring countries, so
each year, transplantation services are provided to
natives of Central Asia and Persian Gulf countries.
Poor, unrelated donors are the most vulnerable
group. Measures such as establishing donor
registries and insuring donors at no charge are
being investigated to provide greater support to
this population. Another important goal is multina-
tional cooperation in the region to prevent organ
trafficking in Middle Eastern countries and interna-
tionally.
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